US 11299737
Compounds and methods for modulating SMN2
granted A61KA61K31/712A61K31/7125
Quick answer
US patent 11299737 (Compounds and methods for modulating SMN2) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/712, A61K31/7125, A61K31/713